Willingness to prescribe aspirin
colorectal cancer
REGRESSION, COLORECTAL CANCER
Most (390/672, 58.0%) GPs were ‘probably willing’ to prescribe aspirin for the hypothetical patient with LS and 22.3% (150/672) were ‘definitely willing’ to prescribe. In total, 19.7% of GPs were unwilling to prescribe (112/672, 16.7% probably not willing; 20/672, 3.0% not at all willing). Willingness to prescribe among GPs was comparable across the three information components (NICE guidance; CAPP2 results; risk and benefit information) (Willingness to prescribe aspirin among GPs presented with each of the three information components (
In the multivariable logistic regression model, GPs who were unsure whether they had previously prescribed aspirin for colorectal cancer prevention were significantly more willing to prescribe aspirin than those who had not prescribed it; however, confidence intervals were wide (OR 5.67, GPs’ willingness to prescribe aspirin by participant characteristics, previous experience, and awareness (


